CD4 and metabolic dysfunction-associated steatotic liver disease: Similarly, BE from NAFLD-HCC subjects attenuated the expansion of total CD4+ T cells (CD3+CD4+) compared to NAFLD-cirrhosis and non-NAFLD control BE (P < 0.0001) (Supplementary Fig. 5c).